IOVANCE BIOTHERAPEUTICS, INC. (22) | Human Resources (10)
Browse by Subcategory
Recent Contracts
-
Executive Employment Agreement, effective as of December 14, 2020, by and between Jean-Marc Bellemin and Iovance Biotherapeutics, Inc
(Filed With SEC on February 25, 2021)
-
Severance Agreement and General Release, effective July 8, 2020, between Iovance Biotherapeutics, Inc. and Timothy Morris
(Filed With SEC on August 6, 2020)
-
Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended
(Filed With SEC on June 9, 2020)
-
Form of Incentive Stock Option Agreement under the Genesis Biopharma Inc. 2011 Equity Incentive Plan
(Filed With SEC on February 25, 2020)
-
Form of Non-Qualified Stock Option Agreement under the Genesis Biopharma Inc. 2011 Equity Incentive Plan
(Filed With SEC on February 25, 2020)
-
Form of Incentive Stock Option Agreement under the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan
(Filed With SEC on February 25, 2020)
-
Form of Non-Qualified Stock Option Agreement under the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan
(Filed With SEC on February 25, 2020)
-
Form of Incentive Stock Option Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan
(Filed With SEC on February 25, 2020)
-
Form of Non-Qualified Stock Option Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan
(Filed With SEC on February 25, 2020)
-
Executive Employment Agreement effective as of July 18, 2019, by and between Friedrich-Reinhard Graf Finck von Finckenstein, M.D
(Filed With SEC on August 1, 2019)